絞り込み

16548

広告

宇宙旅行あと一歩 米ベンチャーが有人実験成功 (毎日新聞)

[PR] 【ワシントン中井正裕】英ヴァージン・グループ傘下の宇宙開発ベンチャー、ヴァージン・ギャラクティック社は13日、カリフォルニア州で宇宙船「スペースシップ...

  1. [企業] Merck &...
  2. 本庶さんノーベル授賞式から帰国 「貴重な...
  3. [企業] 持効インスリンLantusの製...
  4. 調達情報 平成31年度労働保険料等に係る...

ニュース一覧

A modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)₁₋₄₀ and Aβ₁₋₄₂ from the corresponding depsipeptides.

著者 Beeg M , Stravalaci M , Bastone A , Salmona M , Gobbi M
Anal Biochem.2011 Apr 15 ; 411(2):297-9.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Biochemistry and Molecular Pharmacology, Instituto di Ricerche Farmacologiche "Mario Negri", 20156 Milano, Italy. marten.beeg@chem.ethz.ch

スターを付ける スターを付ける     (432view , 0users)

Full Text Sources

Preparing reliable, seed-free stock solutions of the highly amyloidogenic peptides amyloid-β (Aβ) is difficult. Besides the formation of aggregates during synthesis and storage, dissolution of the peptide is a critical step because vortexing can induce aggregation. To overcome this, synthesis of the more water-soluble depsi-Aβ(1-42) peptide, from which the native sequence is easily obtained, has been suggested. We further refined this technique, including a cutoff filtration step and switching the depsipeptide in basic conditions, to stabilize the formed native peptide. The obtained solutions of native Aβ(1-40) and Aβ(1-42) peptides were homogeneous and aggregate free, as indicated by thioflavin T and circular dichroism analysis.
PMID: 21185802 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード